A study of the association between adverse drug reaction and genetic testing: developing a genetic testing and surveillance system for severe adverse drug reaction

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: CHEN, Wan Chun (E-DA Hospital, Pharmacy, Kaohsiung, China Taiwan)
  • Co-author(s): Wang Chun Chen: Pharmacy, E-DA Hospital, Kaohsiung, Taiwan, Province of China
    Hsiu Ling Chang: Pharmacy, E-DA Hospital, Kaohsiung, Taiwan, Province of China
    Yi Ping Hsiang: Pharmacy, E-DA Hospital, Kaohsiung, Taiwan, Province of China
    Chi Hsien Huang: Family Medicine, E-DA Hospital, Kaohsiung, Taiwan, Province of China
  • Abstract:

    Background

    A 2007 report from the Institute of Medicine estimated that between 380,000 and 450,000 preventable adverse drug events (ADEs) occurred annually in United States hospitals. Steven-Johnson syndrome and toxic epidermal necrolysis are acute lethal hypersensitivity reactions on skin. Most possible causes are immunologic reactions to drugs,..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login